Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF)
Clinical trial NCT04343248 · TERMINATED
Trial details
- NCT number
- NCT04343248
- Sponsor
- Romark Laboratories L.C.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2021-02-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.